We offer wide range of services related to bringing your drugs to market faster. Please click on the title of the service for details.
Pharmaceutical Advisory Dream Team (PADT)
|
|
Target Health Inc.'s Pharmaceutical Advisory Dream Team (PADT) consists of a focused, fast-moving and motivated team of highly successful individuals with over 400 years of combined experience in all aspects of pharmaceutical research and development, including: chemistry, product and process development, manufacturing, toxicology, regulatory affairs, clinical research, biostatistics, registration and marketing.
|
Regulatory Affairs
|
|
- Meet with the FDA to discuss and negotiate development strategies
- Prepare and submit:
- Pre-IND/IDE briefing documents
- IND and IND amendments
- IDE
- 510(k)
- NDA
- BLA
- PMA
- DMF
- Export requests
- Establishment registrations
- Orphan Drug requests
- Interact with legal counsel
- Assure that user fee monies are submitted on schedule
- Follow up with FDA on post-NDA submission questions
- Perform pre-inspection GMP audits
- Support responses to FDA questions and warning letters
- Adverse event monitoring and reporting
|
Clinical Research
|
ß
|
- Prepare protocols, case report forms and informed consent forms
- Perform qualification, initiation, monitoring and closeout visits
- Generate investigator study files
- Monitor drug supply
- Identify study sites and manage investigator payments
- Prepare clinical sites for FDA inspection
- Perform Quality Assurance audits
|
Data Management
|
|
- Target e*CRF® Internet-based data collection and project management
- Data Management Plans
- Data Listings
- Edit check specifications
- Batch edit checks
- Online clinical data management
- MedDRA coding
- WHO Drug Coding
|
Biostatistics
|
|
- Statistical Analysis Plans
- Calculate sample size
- Generate randomization codes
- Perform statistical analyses using Statistical Analysis System (SAS®)
- Prepare electronic files, with documentation, in SAS®
|
Medical Writing
|
|
- Write integrated clinical and statistical study reports and other regulatory manuscripts
- Orphan drug designation requests
- NDA Submissions
- application summary
- chemistry, manufacturing and controls
- labels and labeling
- non‑clinical pharmacology and toxicology
- human bioavailability
- clinical/statistical sections including ISS/ISE
- benefit/risk
- drug abuse and overdose
|